In The News

Use of Prior Authorization Impacts 80 Percent of All Commercial Formulary Drugs According to BusinessOne Technologies

The percentage of drugs with prior authorization (PA) on at least one Commercial formulary has increased nearly 20 percent over the past nine years, impacting product performance and patient access, according to BusinessOne Technologies.

Eisai to Educate Physicians on Access to BELVIQ® through Use of BusinessOne Technologies' Market Access Mobile

Eisai and BusinessOne Technologies announced today that Eisai Inc. is using the Maestro Market Access Mobile™ application to educate physicians about detailed coverage levels for Eisai's recently approved BELVIQ® (lorcaserin HCI) CIV.

Sign up for our Newsletter

* Email Address
* First Name
* Last Name